APRINOIA Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 10

APRINOIA Therapeutics General Information

Description

Provider of clinical research and development services intended to establish a drug discovery and early-stage firm. The company's services focus on treatment of neurodegenerative diseases, enabling its clients to receive drugs required to treat human neurological conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 17F, Number 3, Park Street
  • Nangang District
  • Taipei
  • Taiwan
+886 02 0000 0000

APRINOIA Therapeutics Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

APRINOIA Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 27-Jun-2019 000.00 Completed Clinical Trials - General
3. Early Stage VC (Series B) 16-Jan-2018 000.00 000.00 Completed Clinical Trials - General
2. Early Stage VC (Series A) $6M $6.43M Completed Clinical Trials - General
1. Seed Round 20-May-2015 $430K $430K Completed Clinical Trials - General
To view APRINOIA Therapeutics’s complete valuation and funding history, request access »

APRINOIA Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of clinical research and development services intended to establish a drug discovery and early-stage firm. The
Biotechnology
Taipei, Taiwan
000.00
000000000000 000.00

00000000

iam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute ir
0000000000000
New York, NY
00 As of 0000
000.00
000000 - 000 000.00

000000 0

consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nu
000000000000000
San Diego, CA
000 As of 0000
00000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

APRINOIA Therapeutics Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amarantus BioScience Holdings Formerly Accelerator/Incubator backed New York, NY 00 000.00 000000 - 000 000.00
000000 00000000000 Formerly VC-backed San Diego, CA 000 00000 000000&0
000000 (0000 00000 Angel-Backed New York, NY 0 00000 0000000000 00000
000000000 Venture Capital-Backed Boston, MA 00 00000 00000000000 00000
0000000000 Venture Capital-Backed Gaithersburg, MD 00 00000 000
You’re viewing 5 of 12 competitors. Get the full list »

APRINOIA Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Ming-Kuei Jang Ph.D Founder & Chief Executive Officer
Kuo-Ju Pan Director, Operations
Paul Tempest Ph.D Senior Vice President, Drug Discovery
Chin-Yin Tai Ph.D Vice President, Neurobiology
You’re viewing 4 of 5 executive team members. Get the full list »

APRINOIA Therapeutics Board Members (1)

Name Representing Role Since
Kevin Kyung Self Board Member 000 0000
To view APRINOIA Therapeutics’s complete board members history, request access »

APRINOIA Therapeutics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
JLABS Accelerator/Incubator 000 0000 000000 0
Company K Partners Venture Capital Minority 000 0000 000000 0
DCI Partners Venture Capital Minority 000 0000 000000 0
DT & Investment Corporate Venture Capital Minority 000 0000 000000 0
IMM Investment Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »